CVS is reportedly considering buying health-insurance giant Aetna for $66 billion

coapharm2017-10-30T15:26:26+00:00October 30, 2017|

Only 30% of Employers Get Pharmacy Benefit Manager Contracts

coapharm2017-10-30T15:24:21+00:00October 30, 2017|

FDA Taking New Steps to Better Inform Physicians about Biosimilars Through Education about these Potentially Cost-Saving Options

coapharm2017-10-30T15:22:56+00:00October 30, 2017|

Amazon’s Push Into Pharmacy Business Is Full of Promise and Pitfalls

coapharm2017-10-30T15:21:37+00:00October 30, 2017|

Commentary: Loopholes in 340B Drug Discount Program Need Fixes

coapharm2017-10-30T15:19:30+00:00October 30, 2017|

Rapid Flurry of New Drug Pricing Leaves No Room for Public Debate

coapharm2017-10-30T15:13:26+00:00October 30, 2017|

Biosimilars Could Save $54 Billion Over the Next Decade

coapharm2017-10-30T15:12:01+00:00October 30, 2017|

White Paper: DIR Fees Simply Explained

coapharm2017-10-30T15:10:52+00:00October 30, 2017|

Who Is to Blame for the Opioid Crisis?

coapharm2017-10-30T15:09:28+00:00October 30, 2017|

How the Epidemic of Drug Overdose Deaths Rippled Across America

coapharm2017-10-30T15:08:19+00:00October 30, 2017|